Onchain trading surges as perpetual volume hits $972B
Onchain perpetual contracts have surged to $972 billion in trading volume over the past 30 days, even as broader crypto market sentiment remains cautious.
Onchain perpetual contracts have surged to $972 billion in trading volume over the past 30 days, even as broader crypto market sentiment remains cautious.
Cvent, a global leader in meetings and hospitality technology, has entered into a definitive agreement to acquire ON24 (NYSE:ONTF) for approximately $400 million in an all-cash transaction.
Silo Pharma (NASDAQ:SILO) announced a non-binding Letter of Intent (LOI) with Allucent (US) LLC to support the Phase 1 clinical development of SPC-15, a nasal spray formulation under investigation.
Etoiles Capital Group (NASDAQ:EFTY) reported strong financial performance for the six months ended June 30, 2025, with a substantial 196.6% increase in revenue, reaching $1,800,576.
XOMA Royalty (NASDAQ:XOMA) announced the amendment of its 2006 collaboration agreement with Takeda (NYSE:TAK), marking a strategic shift in the economics of their partnership.
The deal, announced on Dec. 30, 2025, will see Takeda regain the majority of XOMA Royalty's economics related to mezagitamab, a monoclonal antibody for inflammatory diseases.
IM Cannabis Corp. (NASDAQ:IMCC) announced on Tuesday that it has launched a comprehensive review of strategic options to enter the United States cannabis market.
The pivot follows a landmark executive order signed by President Donald Trump on Dec. 18, 2025, which directs the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
InflaRx N.V. (NASDAQ:IFRX) provided an update on its Phase 3 study of vilobelimab in pyoderma gangrenosum (PG), outlining multiple data analyses after the trial was terminated earlier this year due to futility, following a recommendation from an Independent Data Monitoring Committee (IDMC).
ZenaTech (NASDAQ:ZENA) finalized three strategic acquisitions on Tuesday, marking its inaugural entry into the Canadian market and bringing its total deal count for 2025 to a staggering 19 companies.
Evogene (NASDAQ:EVGN), a leader in computational chemistry and generative AI for life sciences, announced the appointment of Dr. Olga Nissan as Vice President of Business Development, effective Jan. 1, 2026.
REE Automotive (NASDAQ:REE) reported financial results for the six months ended June 30, 2025, highlighting a strategic shift toward a technology-first and OEM-collaboration model as the company continues to develop its electric vehicle platform.
EUDA Health Holdings (NASDAQ:EUDA) has unveiled a nationwide stem cell extraction, cryostorage, and clinical delivery platform in China, marking a massive expansion of its footprint in the regional longevity and regenerative medicine sector.
Bridger Aerospace Group Holdings (NASDAQ:BAER) has finalized the acquisition of six additional aircraft, a strategic expansion that solidifies its position as the owner of the world’s largest private "Super Scooper" fleet ahead of the 2026 wildfire season.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade